Brief: Guard Therapeutics Q3 Pretax Loss Narrows To SEK 8.0 Mln
Nov 27 (Reuters) - Guard Therapeutics International AB
(publ) GUARD.ST :
* Q3 PRETAX LOSS SEK 8.0 MILLION VERSUS LOSS SEK 16.6
MILLION YEAR
AGO
Source text for Eikon: ID:nBQNmK1xN
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover